Clinical trial
Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis
NCT02457585 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 31, 2015
- Completion date
- April 30, 2018
- Enrollment
- 11 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
takayasu's arteritis